Skip to main content
. 2019 Feb 10;34(5):284–294. doi: 10.1177/0883073819827407

Figure 1.

Figure 1.

Study 232 design. Patients who did not roll over into the extension phase or who discontinued from the study were required to complete the follow-up period.

aFour-week follow-up for patients not enrolling into the extension phase.